Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney by Jing Xu et al.
Xu et al. BMC Nephrology 2013, 14:38
http://www.biomedcentral.com/1471-2369/14/38CASE REPORT Open AccessAutosomal dominant polycystic kidney disease
with ectopic unilateral multicystic dysplastic
kidney
Jing Xu1, Dong-Ping Chen1, Zhi-Guo Mao1, He-Feng Huang2, Chen-Ming Xu2, Cong-Rong Wang3,
Wei-Ping Jia3 and Chang-Lin Mei1*Abstract
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary renal
disorder. In most cases, ADPKD similarly affects bilateral kidneys.
Case presentation: Among the 605 ADPKD patients that were followed up by our center, we identified two male
patients with unilateral ADPKD. The cases were remarkable because the patients also had ectopia and multicystic
dysplasia in the contralateral kidney, which are generally sporadic disease conditions. Both patients tested positive
for polycystic kidney disease 1 mutation, but negative for hepatocyte nuclear factor 1 beta mutation. Moreover, the
deterioration of their kidney function seemed to be quicker than their age- and sex-matched controls and siblings.
Both patients had started a long-term hemodialysis in their 40s.
Conclusion: Anatomical and genetic abnormality in patients with ADPKD may be more frequent and complex than
previously believed. The compensatory capacity in patients with ADPKD is fragile, and missing one kidney could
accelerate the deterioration of renal function.
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Autosomal dominant polycystic kidney disease (ADPKD)
is the most common hereditary renal disorder and the
fourth cause of death of end-stage renal disease, ac-
counting for 10% of patients on dialysis [1]. The disease is
caused by mutations in the PKD1 (85% of cases) or PKD2
(15% of cases) [2]. In most ADPKD patients, bilateral
kidneys are similarly affected, with numerous fluid-filled
cysts arising from different nephron segments. Only a few
cases of ADPKD with unilateral renal agenesis or severe
hypoplasia have been reported [2].
Among the 605 ADPKD patients followed by our cen-
ter, we report two cases of ADPKD patients with pelvic
ectopic unilateral multicystic dysplastic kidney (MCDK),
which refers to a sporadic disease condition and is related
to transcription factor 2 (TCF2) mutations [3]. The clinical* Correspondence: chlmei@hotmail.com
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reproduction in any medium, provided the orcharacteristics of these two rare cases were compared with
their siblings and other male ADPKD patients with similar
ages; these characteristics were then summarized and
analyzed. The PKD1 and PKD2 mutations and the rele-
vant MCDK (TCF2) mutations were also measured.Case presentation
Case 1
A 48-year-old man with ADPKD was admitted for long-
term hemodialysis because his estimated glomerular
filtration rate (eGFR) dropped to 14 ml/min/1.73 m2.
His blood pressure was within the normal range. The
patient was diagnosed with ADPKD 10 years earlier with
a positive family history (Figure 1). He and his relatives
had no history of intracranial aneurysm. He had no albu-
minuria and did not complain of renal pain. During
diagnosis, an enlarged polycystic left kidney was found,
but the right kidney was absent. An ultrasonography after
admission detected a fist-sized, multi-cystic mass located
before his right iliac artery. An enlarged polycystic liverThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
??
Figure 1 Family tree of Case 1 patient. (Arrow): affected proband with unilateral ADPKD; (filled square, filled circle): male/female affected by
ADPKD with two kidneys; (blank square, blank circle): male/female did not have ADPKD; (?): unsure for ADPKD; (box with a stripe): family member
passed away.
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scan confirmed a 6 cm diameter polycystic mass in the
right pelvis (Figure 2, Panels A and B, triangles), and the
left kidney was significantly enlarged, measuring 18 cm×
12 cm× 8 cm. A renal volume assessment was then
performed. The renal volume for the left kidney was
1127.6 cm3 and that for the right was only 74.6 cm3.
Further MR urography revealed a tubular structure con-
necting the pelvic polycystic mass to the bladder with a
fluid signal along the tubular lumen area (Figure 2, Panels
B and C, arrows). This ADPKD patient had a right pelvic
multicystic kidney with congenital aplasia, and the tubular
structure was his right ureter.
Case 2
A 45-year-old male with fatigue and elevated creatinine
(542 μmol/l, eGFR = 14 ml/min/1.73 m2) was admitted
to set up long-term vascular access. The patient had
hypertension controlled with nifedipine. No history of
intracranial aneurysm was reported. He had a positive
family history (Figure 3) and was diagnosed with ADPKD
through an ultrasonography 16 years prior this study. HeFigure 2 MRI scans showing a solitary left polycystic kidney with con
(arrow): right ureter.had no albuminuria and did not complain of renal pain.
During diagnosis, an exaggerated right kidney was found.
However, the left kidney was absent. After admission, MR
urography detected a 22.8 cm × 12.2 cm × 10.5 cm right
kidney with a typical polycystic phenotype, and a 5.8 cm ×
4.2 cm × 3.9 cm multicystic space-occupying lesion before
the left psoas (Figure 4, Panels A and B, triangles), with
signals similar to the right polycystic kidney, indicating a
small left pelvic kidney with multicystic aplasia. Based
on renal volume assessment, the left kidney measured
2290.7 cm3, whereas the right one only measured 44.0 cm3.
A polycystic liver was also detected. The CT scan result
agreed with that of MR urography.
Screening and genotyping
No ectopic aplastic cystic kidney was detected among
the family members of these two patients, both affected
and non-affected, who were screened using abdominal
ultrasonography. These two patients were the only ones
with this presentation among their families. A genetic
analysis of PKD1 and PKD2 was performed by Athena




Figure 3 Family tree of Case 2 patient. (Arrow): affected proband with unilateral ADPKD; (filled square, filled circle): male/female affected by
ADPKD with two kidneys; (blank square, blank circle): male/female not had ADPKD; (?): not sure for ADPKD; (box with a stripe): deceased
family member.
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Genotyping of the two cases indicated that each had
different mutations in the PKD1 gene. Case 1 had a pro-
line in place of leucine at amino acid 55 and a premature
termination signal in codon 60 in exon 1 [NM_000296.3
P.L56PfsX60 (168_174dupCGCGGGC,novel,Het)]. Case
2 had a 7 bp duplication mutation (11650_11651) in exon
41, resulting in a frameshift at amino acid 3814, which is a
predicted disease-associated mutation. He also had two
nonsense mutations in exon 15 (an A in place of a G at
nucleotide position of 6625) and exon 23 (an A in place of
a G at nucleotide position of 8851). None of these po-
lymorphisms had been previously reported.
Both patients tested negative for TCF2 mutation, also
known as hepatocyte nuclear factor 1 beta (HNF1β).
Comparison of the reported cases to age- and sex-
matched controls with bilateral ADPKD or siblings
A matched control group for each case was defined
among the remaining 603 patients with ADPKD
followed up by our center. All patients with the same
sex and age (with no more than a five-year difference)
from the respective ages of the cases were recruited.
Three of their age- and sex-matched siblings were also
chosen as another control group (Table 1). The single-Figure 4 MRI scans showing a solitary right polycystic kidney
with contralateral MCDK in Case 2 patient. (Triangle): left
ectopic MCDK.kidney volume (SKV) and eGFR were expressed as mean
and 95% confidence interval (CI). Compared with the
matched bilateral ADPKD controls, the median SKV of
the ectopic MCDK kidneys of the two reported cases
were significantly smaller [Case 1: 74.6 vs. 692.4 95% CI
(611.3, 781.3) cm3; Case 2: 44.0 vs. 657.1 95% CI (566.9,
743.4) cm3]. However, the SKV of their normal contralat-
eral kidneys seemed to be significantly larger [Case 1:
1127.6 vs. 692.4 95% CI (611.3, 781.3) cm3; Case 2: 2290.7
vs. 657.1 95% CI (566.9, 743.4) cm3]. The mean eGFR of
the two cases were significantly lower than their age- and
sex-matched siblings (14.0 vs. 68.3, 39.6, 65.0 ml/min/
1.73 m2) and bilateral ADPKD controls [Case 1: 14.0 vs.
84.7 95% CI (77.7, 91.7) ml/min/1.73 m2; Case 2: 14.0 vs.
88.8 95% CI (81.7, 96.4) ml/min/1.73 m2].
Discussion
In most cases, bilateral kidneys are involved in ADPKD
patients. No previous report has been conducted on uni-
lateral ADPKD with contralateral ectopic MCDK.
Among the 605 patients followed up by our center, we
identified two subjects with unilateral ADPKD. No kid-
ney tissue on the contralateral location was found on
both patients’ kidneys. MRI revealed ectopic dysplasia
kidney remnants with multiple cysts in the pelvis. Both
patients had advanced disease during presentation.
Compared with their matched bilateral ADPKD controls,
the median SKV of the ectopic MCDK kidneys of the
two reported cases were significantly smaller (Table 1),
whereas their contralateral kidneys were significantly lar-
ger. The mean eGFR of the two cases (Table 1), which
indicated a more advanced stage of disease progression
with the unilateral ADPKD, were significantly lower than
their age- and sex-matched siblings and bilateral ADPKD
controls.
In a cohort of 182 patients with ADPKD, Poster et al.
[2] identified three patients with unilateral renal agenesis
or severe hypoplasia. These three cases had different
truncating mutations in their PKD1 gene. Although their
kidney volumes and volume progression rates were
greater than the mean values of their two polycystic kid-
ney controls, which is normally associated with an
Table 1 Kidney volumes and renal function in two patients with ectopic unilateral MCDK compared with their age- and
sex-matched siblings and bilateral ADPKD controls
Parameter Case 1 Age- and sex-matched
bilateral ADPKD for case 1
Case 2 Age- and sex-matched
bilateral ADPKD for case 2
Age- and sex-matched
siblings
No. of Patients 1 66 1 60 3
Age 48.0 47.9 45.0 45.6 41, 47, 49
Mean (range) (43.2, 53.0) (40.3, 49.7)
SKV (cm3) Left: 1127.6 692.4 Right: 2290.7 657.1 NA
Mean (95%CI) Right: 74.6 (611.3, 781.3) Left: 44.0 (566.9, 743.4)
eGFR (ml/min/1.73 m2) 14.0 84.7 14.0 88.8 68.3, 39.6, 65.0
Mean (95%CI) (77.7, 91.7) (81.7, 96.4)
MCDK: multicystic dysplastic kidney; ADPKD: autosomal dominant polycystic kidney disease; SKV: single-kidney volume; eGFR: estimated glomerular filtration rate;
NA: not available.
Xu et al. BMC Nephrology 2013, 14:38 Page 4 of 5
http://www.biomedcentral.com/1471-2369/14/38accelerated decrease in renal function, the eGFR in these
patients was remarkably well-preserved [4]. This charac-
teristic may be partly due to compensatory parenchymal
hypertrophy. However, renal parenchyma is unlikely to
make a large contribution to the total kidney volume
because the enlarged single cystic kidneys were grossly
cystic, as shown in the MRI images [2]. Moreover, all
their patients were much younger than ours (23 years old,
38 years old, and 40 years old), and the disease pro-
gressions of the three subjects after long-term follow-up
remain unknown. The two patients in the present study
had different mutations on the PKD1 gene. The relation-
ship between the PKD1 mutation sites and the disease
progression was difficult to explain because of the small
sample size limitation of the reported cases.
Apart from unilateral ADPKD, our patients also had
concurrent ectopic MCDK. MCDK generally refers to a
sporadic disease condition of abnormal metanephric
differentiation. The incidence is approximately 1 in 4300
in the general population [3]. We identified two cases of
MCDK among the 605 ADPKD patients, indicating an
incidence rate of 3.3%. Generally, the total kidney func-
tion of many subjects with MCDK could be well-
maintained [5]. However, both our patients prepared for
long-term hemodialysis when they were in their 40s,
mainly in consideration of the kidney structure destruc-
tion by the continuous cyst growth in their contralateral
kidneys.
TCF2 (HNF1β) abnormalities cause congenital anom-
alies of the kidney and urinary tract [6]. Some studies
have reported that MCDK is related to TCF2 mutation
[7,8]. However, both of our patients tested negative for
TCF2 mutation. Mutations in genes such as EYA1, SIX1,
and PAX2 are related to the occurrence of MCDK. How-
ever, neither of our patients had concomitant ear and
eye structural abnormalities or dysfunction (data not
shown). Their MCDK could be related to other genetic
abnormalities.Conclusions
We conclude that the anatomical and genetic abnormal-
ity in patients with ADPKD could be more frequent and
complex than previously believed. Patients with ADPKD
have fragile compensatory capacities, and missing one
kidney could accelerate the deterioration of the renal
function.
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